Major Autohemotherapy (MAH)

What is the Process for Major Ozone Autohemotherapy Treatment?

Major ozone autohemotherapy (MAH) is a type of ozone therapy that involves the administration of ozone into the bloodstream through autohemotherapy, which is the withdrawal of a patient's blood, exposure to ozone, and reinfusion into the body.

During the MAH process, a small amount of blood is withdrawn from the patient and mixed with a medical-grade ozone-oxygen mixture. The mixture is then reinfused into the patient's body.

The amount of ozone used in the mixture can vary depending on the patient's condition but generally ranges from 10 to 60 µg/mL. The treatment can last anywhere from 10 minutes to an hour, and the frequency and duration of treatment sessions depend on the individual patient's needs.

What is the Difference Between Major Autohemotherapy (MAH) and Ozone High-Dose Therapy (OHT)?

While both MAH and ozone high-dose therapy (OHT) involves the administration of ozone into the bloodstream through autohemotherapy, there are some key differences between the two treatments.

MAH involves the use of a lower concentration of ozone (between 10 to 60 µg/mL) and is typically performed more frequently (two to three times per week) over a longer period of time (several months). OHT, on the other hand, involves the use of a higher concentration of ozone (up to 70 µg/mL) and is typically performed less frequently (once or twice per week) over a shorter period of time (a few weeks to a few months).

What is the Difference Between Minor Autohemotherapy and Major Autohemotherapy?

Autohemotherapy is a treatment where a patient's blood is withdrawn and re-injected to address various health conditions. There are two types of autohemotherapy: minor and major. The difference between the two is the amount of blood withdrawn and re-injected.

Minor autohemotherapy involves withdrawing a small amount of blood, typically around 10 milliliters, from the patient and then injecting it back into the patient's muscle tissue. This stimulates the immune system and is often used to treat allergies, infections, and autoimmune diseases.

On the other hand, major autohemotherapy involves withdrawing much more blood, often around 200 milliliters, and mixing it with an ozone-oxygen mixture before re-injecting it into the patient's bloodstream. This process stimulates the immune system more profoundly and is used to treat more severe health conditions, including cancer.

The major difference between minor and major autohemotherapy is the amount of blood that is withdrawn and the way in which it is re-injected. While minor autohemotherapy is generally considered safe and is associated with minimal risks, major autohemotherapy carries a slightly higher risk due to the larger amount of blood being withdrawn and re-injected.

What are the Risks of Major Autohemotherapy?

While major autohemotherapy has been shown to be an effective treatment for a variety of health conditions, such as Cancer at Brio-Medical, there are some risks associated with the procedure. The most common risks include:

1. Infection: Anytime the skin is penetrated, there is a risk of infection. This risk is minimized by using sterile techniques and equipment during the procedure.
2. Bleeding: Withdrawing a large amount of blood can increase the risk of bleeding. Patients who are taking blood-thinning medications or who have a bleeding disorder may not be good candidates for major autohemotherapy.
3. Allergic reaction: Some patients may be allergic to the ozone-oxygen mixture used in major autohemotherapy. This risk can be minimized by performing a small skin test prior to the procedure.
4. Fatigue: After major autohemotherapy, some patients may experience fatigue or weakness. This is a normal side effect and typically resolves within a few days.

Like any medical procedure, there are potential risks associated with major autohemotherapy (MAH). However, the risks associated with MAH are generally low and are typically outweighed by the potential benefits.

Who Can Not Receive Ozone Autohemotherapy Treatment?

While ozone autohemotherapy has been shown to be an effective treatment for various health conditions, certain groups of people may not be good candidates for the procedure. These include:

1. Pregnant women: The effects of ozone on developing fetuses are not well understood, so it is recommended that pregnant women avoid ozone therapy.

   Pregnancy is a delicate state that requires caution regarding any form of treatment. Autohemotherapy, which involves the withdrawal and re-injection of blood, may pose some risks to pregnant women. This is because, during pregnancy, the body undergoes numerous changes that can affect the body's ability to handle certain treatments.

   Autohemotherapy may lead to anemia in pregnant women, a condition in which the body doesn't have enough red blood cells to carry oxygen to the body's tissues. This can be dangerous to both the mother and the baby, as it can lead to complications such as preterm labor, low birth weight, and developmental problems in the baby. Additionally, the use of heparin during autohemotherapy can pose a risk to pregnant women, as heparin can increase the risk of bleeding and other complications during pregnancy.

2. GD6P Glucose-6-Phosphate Dehydrogenase) Deficiency:

   GD6P deficiency is a genetic disorder that affects the body's ability to produce a specific enzyme, which can lead to a buildup of certain types of sugars in the body's cells. Autohemotherapy may not be suitable for individuals with GD6P deficiency, as the use of heparin during treatment may pose a risk to these individuals. Heparin has been shown to inhibit the function of the enzyme affected by GD6P deficiency, which can lead to a further buildup of sugars in the body's cells.

   Furthermore, individuals with GD6P deficiency may be at an increased risk of developing anemia during autohemotherapy. This is because the condition can affect the production of red blood cells in the body, which can lead to a decreased ability to carry oxygen to the body's tissues. Individuals with GD6P deficiency should consult with their healthcare provider before considering autohemotherapy as a form of treatment.

3. People with hyperthyroidism: Ozone therapy has been shown to stimulate the thyroid gland, which can exacerbate symptoms in people with hyperthyroidism.

   Hypothyroidism is when the thyroid gland doesn't produce enough thyroid hormone. This can lead to many symptoms, such as fatigue, weight gain, constipation, and depression. Autohemotherapy is a form of treatment involving the withdrawal of blood from a patient and re-injection into the patient's body. While autohemotherapy is generally considered safe, individuals with hypothyroidism should be cautious when considering this therapy.

   The thyroid gland plays a vital role in regulating the body's metabolism, which is the rate at which the body burns calories to produce energy. Hypothyroidism can lead to a slowdown in the metabolism, causing individuals to gain weight and feel fatigued. The use of autohemotherapy in individuals with hypothyroidism may lead to an increased demand for thyroid hormones, which can exacerbate the symptoms of hypothyroidism.

4. Active Bleeding or Acute Hemorrhagic Disease (i.e., Hemophilia): People with active bleeding or acute hemorrhagic disease, such as hemophilia, have a higher risk of bleeding complications. Hemophilia is a genetic disorder that impairs the body's ability to control blood clotting. In these individuals, the blood takes longer to clot, leading to excessive bleeding or even internal bleeding. The procedure can aggravate their condition, leading to life-threatening complications.

5. Acute MI (acute myocardial infarction): Also known as a heart attack, Acute MI is a medical emergency caused by obstructing the blood supply to the heart muscle. This condition requires immediate medical intervention, and autohemotherapy may interfere with the standard treatment procedures. The procedure can also pose a risk of further heart damage, leading to more severe complications.

6. Allergy to Heparin: Heparin is a blood-thinning medication that can prevent blood clots from forming or growing larger in the body. Some people may develop an allergy to heparin, leading to serious allergic reactions. Autohemotherapy involves the use of heparin in the process. People with a known allergy to heparin should not undergo this treatment as it can trigger an allergic reaction that can be life-threatening. It is important to identify potential allergies before any procedure that involves heparin to prevent severe reactions.